Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes

Resultado final

Individualized press release for every partner
Development of the project logo
Launch of website
Twitter, Facebook, LinkedIn, Account Setup

Report on the status of the posting of results to the study registry

Publicaciones

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Autores: Maria VD Soares, Virginia Escamilla Gomez, Rita I Azevedo, Paulo N.G. Pereira, Teresa Caballero Velázquez, Clara B. Garcia-Calderón, Kukatharmini Tharmaratnam, Inês A Cabral, Ana C Ribeiro, Laura Mendes, Clara Juncal, Susana Roncon, Ana Teresa Pais, Ana C Alho, Alfonso Rodriguez Gil, Eduardo L Espada, Anabela Rodrigues, Ana Garção, Marie-Laure Yaspo, Hans-Jörg Warnatz, Hans Lehrach, Nuno L.
Publicado en: Edición Blood (2022) 140 (Supplement 1), 2022, Página(s) 880–882.
Editor: The American Society of Hematology
DOI: 10.1182/blood-2022-163394

High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Autores: Caroline Ritacco; Grégory Ehx; Céline Gregoire; Coline Daulne; Evelyne Willems; Sophie Servais; Yves Beguin; Frédéric Baron
Publicado en: Journal, Edición 2, 2021, ISSN 0268-3369
Editor: Nature Publishing Group
DOI: 10.1038/s41409-021-01221-0

Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells

Autores: Riegel, Christin; Boeld, Tina J.; Doser, Kristina; Huber, Elisabeth; Hoffmann, Petra; Edinger, Matthias
Publicado en: Leukemia, Edición 1, 2019, ISSN 0887-6924
Editor: Nature Publishing Group
DOI: 10.1038/s41375-019-0625-3

Resultado final

Publicaciones

Compartir esta página

Descargar